Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Results from new collaboration between Alfacell and University of Frankfurt

Jan. 31, 2002

Compounds useful in hyperproliferative disorders claimed by Pfizer

Jan. 30, 2002

Sugen claims compounds that modulate protein kinases and phosphatases

Jan. 30, 2002

MG-98 enters clinical trials in MDS and AML

Jan. 30, 2002

Novel caspase inhibitors identified at Vertex

Jan. 29, 2002

Schering AG and Mologen to develop cell-based therapies

Jan. 29, 2002

Iressa under regulatory review in two major markets for NSCLC

Jan. 29, 2002

Human Genome Sciences submits IND for B-cell-targeting LymphoRad

Jan. 28, 2002

Cell Pathways updates phase IIa program of CP-461 in cancer

Jan. 28, 2002

Tubulin-binding agents from AstraZeneca with antiangiogenic activity

Jan. 25, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...